MICHELLE TURNER: Open Payments
NPI 1538109954 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,652 in 41 payments from 8 companies in 2025. Trend: 2023 $51,597 · 2024 $17,281 · 2025 $22,652
Speaker / faculty: $18,900Food & beverage: $1,447Travel & lodging: $1,305Consulting: $1,000
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $22,069 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $182 |
| Janssen Biotech, Inc. | 1 | $132 |
| Exelixis Inc. | 1 | $123 |
| JAZZ PHARMACEUTICALS INC. | 1 | $84 |
| Incyte Corporation | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: IMFINZI, TAGRISSO, Nubeqa, RYBREVANT, CABOMETYX, ZEPZELCA, Stivarga.
Industry payments across MD — which companies pay providers there.
